- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-DNMT3A
DNMT3A Polyclonal Antibody for WB, IHC, IF/ICC, IP, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, IP, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 20954-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
20954-1-PBS cible DNMT3A dans les applications de WB, IHC, IF/ICC, IP, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | DNMT3A Protéine recombinante Ag15111 |
| Nom complet | DNA (cytosine-5-)-methyltransferase 3 alpha |
| Masse moléculaire calculée | 912 aa, 102 kDa |
| Poids moléculaire observé | 120-130 kDa |
| Numéro d’acquisition GenBank | BC043617 |
| Symbole du gène | DNMT3A |
| Identification du gène (NCBI) | 1788 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
DNA methylation in vertebrate animals is an epigenetic modification that is important for embryonic development, imprinting, and the inactivation of X chromosomes. DNA methylation is catalyzed by a family of DNA methyltransferases (DNMTs) that include the maintenance enzyme DNMT1 and de novo methyltransferases DNMT3a and DNMT3b. The overexpression of DNMT1, DNMT3a, and DNMT3b has been reported in various malignancies, including gastric, urothelial, and lung cancers, and may be related to tumorigenesis, tumor progression, and poor survival. Two isoforms of DNMT3a exist: the full-length DNMT3a, and the shorter form DNMT3a2 which lacks the N-terminal fragment. DNMT3a is expressed ubiquitously at low levels, while DNMT3a2 is specially expressed at high levels in embryonic stem cells and shows restricted expression in tissues known to undergo de novo methylation including testis and ovary. This antibody was raised against the N-terminal region of human DNMT3a. It is expected to detect the 120-130 kDa DNMT3a but not 72-100 kDa DNMT3a2.



























